3.3-Å resolution cryo-EM structure of human ribonucleotide reductase with substrate and allosteric regulators bound.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29460780.
- Also identified by DOI 10.7554/eLife.31502 and PMC identifier 5819950.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ribonucleotide reductases (RNRs) convert ribonucleotides into deoxyribonucleotides, a reaction essential for DNA replication and repair. Human RNR requires two subunits for activity, the α subunit contains the active site, and the β subunit houses the radical cofactor. Here, we present a 3.3-Å resolution structure by cryo-electron microscopy (EM) of a dATP-inhibited state of human RNR. This structure, which was determined in the presence of substrate CDP and allosteric regulators ATP and dATP, has three α<sub>2</sub> units arranged in an α<sub>6</sub> ring. At near-atomic resolution, these data provide insight into the molecular basis for CDP recognition by allosteric specificity effectors dATP/ATP. Additionally, we present lower-resolution EM structures of human α<sub>6</sub> in the presence of both the anticancer drug clofarabine triphosphate and β<sub>2</sub>. Together, these structures support a model for RNR inhibition in which β<sub>2</sub> is excluded from binding in a radical transfer competent position when α exists as a stable hexamer.
Medical subject headings
- Protein Multimerization
- Ribonucleotide Reductases